Shortage of 2 billion syringes in 2022, warns WHO
Geneva: The World Health Organization (WHO) warned Tuesday there could be shortfall of up to two billion syringes in 2022, which threatens to hamper vaccine efforts globally is production does not improve.The shortages are the result of Covid-19 vaccine campaigns, with billions more syringes than normal being used worldwide, badly denting global supplies.Lisa Hedman, the WHO's senior advisor...
Login or Register to read the full article
Geneva: The World Health Organization (WHO) warned Tuesday there could be shortfall of up to two billion syringes in 2022, which threatens to hamper vaccine efforts globally is production does not improve.
The shortages are the result of Covid-19 vaccine campaigns, with billions more syringes than normal being used worldwide, badly denting global supplies.
Lisa Hedman, the WHO's senior advisor on access to medicines and health products, said as the supply of Covid-19 vaccine doses increases, the supply of syringes needs to keep pace.
"We are raising the real concern that we could have a shortage of immunisation syringes, which would in turn lead to serious problems, such as slowing down immunisation efforts," she told reporters.
"Depending on how the vaccine uptake goes, it could be a deficit of anywhere from one billion to two billion."
More than 7.25 billion Covid-19 vaccine doses have been administered globally, according to an AFP tally.
That's nearly double the number of routine vaccinations given per year -- and twice the number of syringes required.
Hedman said one serious result of a shortage could be delays in routine vaccinations, which could have a public health impact "for years to come" if a generation of youngsters miss out on normal childhood vaccinations.
Shortages could also lead to the unsafe practice of reusing syringes and needles.
Hedman said any constraint on syringe supply could only be worsened by export restrictions and transportation problems.
She urged countries to plan syringe needs well in advance to avoid hoarding and panic buying situations.
Hedman said "efforts are being made to reduce that risk to zero in terms of the actual number that we could be short".
Read also: Novavax files for COVID vaccine EUL with WHO
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd